Today: 11 June 2026
Caterpillar stock ends 2025 lower — what investors are watching for CAT in January
1 January 2026
1 min read

Caterpillar stock ends 2025 lower — what investors are watching for CAT in January

NEW YORK, December 31, 2025, 21:11 ET — Market closed

  • Caterpillar fell about 0.8% to close at $572.87 as Wall Street finished the year with a pullback
  • Investors are sizing up 2026 demand against interest-rate and trade-policy uncertainty
  • Focus shifts to January catalysts, including CES, the next dividend date and expected earnings timing

Caterpillar Inc shares slipped about 0.8% on Wednesday to close at $572.87, as U.S. stocks ended the year’s final session lower.

The move matters because Caterpillar is widely treated as a read-through on capital spending, from construction equipment to mining and energy projects. With 2026 starting amid shifting rate expectations and trade uncertainty, investors are using late-year price action as a quick gauge of risk appetite.

Caterpillar is also coming off a strong 2025 run, leaving the stock more sensitive to profit-taking and any reset in expectations around the “AI infrastructure” theme that has broadened beyond chipmakers. Barron’s

The Dow fell 0.63% and the S&P 500 dropped 0.74% in light trading on the last day of 2025, Reuters reported. Treasury yields moved higher after a labor-market report showed an unexpected dip in new filings for unemployment benefits.

Caterpillar traded between $572.05 and $578.94 during the session, according to Yahoo Finance historical data.

Recent investor focus has extended to Caterpillar’s engine and power generation offerings as data-center operators look for faster ways to secure electricity for new buildouts, Barron’s reported.

Mizuho analyst Jordan Klein underscored the industrial scale of the opportunity, writing: “We are not talking small generators you put next to the house.” Barron’s

Beyond the data-center angle, traders are watching for signals on the core cycle: equipment demand tied to construction and resource markets, dealer inventory levels, and how pricing holds up if financing costs stay restrictive into early 2026.

U.S. markets are closed Thursday for New Year’s Day, according to the New York Stock Exchange holiday calendar.

Before the next session, some traders will be watching whether Caterpillar holds the $570 area after Wednesday’s close, with the stock still below its 52-week high of $627.50, market data showed.

On the company calendar, CEO Joe Creed is scheduled to deliver a keynote at CES in Las Vegas on Jan. 7, an event that could put Caterpillar’s technology and power-generation messaging back in focus for investors.

Income investors also have the next dividend marker ahead: Caterpillar’s shares are set to go ex-dividend on Jan. 20 — meaning buyers after that date won’t receive the next payout — for a $1.51 quarterly dividend payable Feb. 19, the company’s investor site shows.

Wall Street also expects the company’s next earnings update in late January; Nasdaq’s earnings calendar

Stock Market Today

  • Live Cattle Futures Edge Higher Amid Mixed USDA Beef Prices
    June 11, 2026, 10:54 AM EDT. Live cattle futures rose by $1.45 to $1.60 across most front months on Wednesday, with December delivery slightly down. Feeder cattle futures gained $2.40 to $2.90 by midday. Open interest increased by 1,293 contracts. Managed money trimmed net long positions in live cattle futures and options by 7,083 contracts, totaling 101,265, while feeder cattle spec funds reduced holdings by 470 contracts. USDA reported a decline in wholesale boxed beef prices, with Choice boxes down $1.68 to $359.36 and Select down $3.15 to $344.88. Federally inspected cattle slaughter rose to an estimated 123,000 head Wednesday, exceeding last week but falling short of last year. The mixed data signals ongoing volatility in cattle markets as traders assess supply and demand factors.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Previous Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop